Abstract
We have developed an efficient copper-catalyzed method for the
synthesis of 4-aminoquinazoline and 2,4-diaminoquinazoline derivatives
via reactions of substituted 2-bromo-benzonitriles with amidines
or guanidine, and the method is of economical and practical advantage.
Key words
copper - Ullmann-type reaction - cross-coupling - quinazoline - synthetic method
References and Notes
<A NAME="RW15209ST-1">1 </A>
Ple PA.
Green TP.
Hennequin LF.
Curwen J.
Fennell M.
Allen J.
Lambertvan der Brempt C.
Costello G.
J. Med.
Chem.
2004,
47:
871
<A NAME="RW15209ST-2A">2a </A>
Colotta V.
Catarzi D.
Varano F.
Lenzi O.
Filacchioni G.
Costagli C.
Galli A.
Ghelardini C.
Galeotti N.
Gratteri P.
Sgrignani J.
Deflorian F.
Moro S.
J. Med. Chem.
2006,
49:
6015
<A NAME="RW15209ST-2B">2b </A>
Lewerenz A.
Hentschel S.
Vissiennon Z.
Michael S.
Nieber K.
Drug Dev.
Res.
2003,
58:
420
<A NAME="RW15209ST-3">3 </A>
Malecki N.
Carato P.
Rigo G.
Goossens JF.
Houssin R.
Bailly C.
Henichart JP.
Bioorg.
Med. Chem.
2004,
12:
641
<A NAME="RW15209ST-4A">4a </A>
Doyle LA.
Ross DD.
Oncogene
2003,
22:
7340
<A NAME="RW15209ST-4B">4b </A>
Henderson EA.
Bavetsias V.
Theti DS.
Wilson SC.
Clauss R.
Jackman AL.
Bioorg.
Med. Chem.
2006,
14:
5020
<A NAME="RW15209ST-5A">5a </A>
Chien T.-C.
Chen C.-S.
Yu F.-H.
Chern J.-W.
Chem. Pharm.
Bull.
2004,
52:
1422
<A NAME="RW15209ST-5B">5b </A>
Herget T.
Freitag M.
Morbitzer M.
Kupfer R.
Stamminger T.
Marschall M.
Antimicrob. Agents Chemother.
2004,
48:
4154
<A NAME="RW15209ST-6A">6a </A>
Waisser K.
Gregor J.
Dostal H.
Kunes J.
Kubicova L.
Klimesova V.
Kaustova J.
Farmaco
2001,
56:
803
<A NAME="RW15209ST-6B">6b </A>
Kunes J.
Bazant J.
Pour M.
Waisser K.
Slosarek M.
Janota J.
Farmaco
2000,
55:
725
<A NAME="RW15209ST-7A">7a </A>
Nakagami K,
Yokoi S,
Nishimura K,
Nagai S,
Honda T,
Oda K,
Fujii K,
Kobayashi R, and
Kojima M. inventors;
US 4323680.
<A NAME="RW15209ST-7B">7b </A>
Haley GJ. inventors; US 5373011.
<A NAME="RW15209ST-8A">8a </A>
Palanki MSS, and
Suto MJ. inventors; US 5939421.
<A NAME="RW15209ST-8B">8b </A>
Myers MR,
Spada AP,
Maguire MP,
Persons
PE,
Zilberstein A,
Hsu C.-Y.-J, and
Johnson SE. inventors;
US 5714493.
<A NAME="RW15209ST-9A">9a </A>
Barker AJ. inventors; US 5942514.
<A NAME="RW15209ST-9B">9b </A>
Barker AJ. inventors;
US 5932574.
<A NAME="RW15209ST-10A">10a </A>
Nauta WT. inventors; US 3980650.
<A NAME="RW15209ST-10B">10b </A>
Mizogami S,
Hiranuma H,
Sekiya T, and
Hanazuka M. inventors; US 4607034.
<A NAME="RW15209ST-11A">11a </A>
Elslager EF.
Davoll J. In
Lectures in Heterocyclic Chemistry 2
Castle RN.
Townsend LB.
Hetero Corp.;
Orem
Utah (USA):
1974.
<A NAME="RW15209ST-11B">11b </A>
Elslager EF.
Johnson JL.
Werbel LM.
J. Med. Chem.
1983,
26:
1753
<A NAME="RW15209ST-12">12 </A>
Grivsky EM.
Lee S.
Sigel CW.
Duch DS.
Nichol CA.
J.
Med. Chem.
1980,
23:
327
<A NAME="RW15209ST-13A">13a </A>
Bertino JR.
Sawacki WL.
Moroson BA.
Cashmore AR.
Elslager EF.
Biochem.
Pharmacol.
1979,
28:
1983
<A NAME="RW15209ST-13B">13b </A>
Weir EC.
Cashmore AR.
Dreyer RN.
Graham ML.
Hsiao N.
Moroson BA.
Sawacki WL.
Bertino JR.
Cancer Res.
1982,
42:
1696
<A NAME="RW15209ST-13C">13c </A>
Duch DS.
Edelstein MP.
Bowers SW.
Nichol CA.
Cancer
Res.
1982,
42:
3987
<A NAME="RW15209ST-13D">13d </A>
Lin JT.
Cashmore AR.
Baker M.
Dreyer RN.
Ernstoff M.
Marsh JC.
Bertino JR.
Whitfield LR.
Delap R.
Grillo-Lopez A.
Cancer
Res.
1987,
47:
609
<A NAME="RW15209ST-13E">13e </A>
Kovacs JA.
Allegra CA.
Swan JC.
Drake JC.
Parillo JE.
Chabner BA.
Masur H.
Antimicrob.
Agents Chemother.
1988,
32:
430
<A NAME="RW15209ST-14">14 </A>
Am. J. Hosp. Pharm.
1994,
51:
591
<A NAME="RW15209ST-15A">15a </A>
Graffner-Nordberg M.
Fyfe M.
Brattsand R.
Mellgård B.
Hallberg A.
J. Med. Chem.
2003,
46:
3455
<A NAME="RW15209ST-15B">15b </A>
Graffner-Nordberg M.
Marelius J.
Ohlsson S.
Persson A.
Swedberg G.
Andersson P.
Andersson SE.
Åqvist J.
Hallberg A.
J. Med. Chem.
2000,
43:
3852
<A NAME="RW15209ST-15C">15c </A>
Graffner-Nordberg M.
Kolmodin K.
Åqvist J.
Queener SF.
Hallberg A.
J. Med. Chem.
2001,
44:
2391
<A NAME="RW15209ST-16">16 </A>
Thurmond J.
Butchbach MER.
Palomo M.
Pease B.
Rao M.
Bedell L.
Keyvan M.
Pai G.
Mishra R.
Haraldsson M.
Andresson T.
Bragason G.
Thosteinsdottir M.
Bjornsson JM.
Coovert DD.
Burghes AHM.
Gurney ME.
Singh J.
J.
Med. Chem.
2008,
51:
449
<A NAME="RW15209ST-17A">17a </A>
Chowdhury SF.
Villamor VB.
Guerrero RH.
Leal I.
Brun R.
Croft SL.
Goodman JM.
Maes L.
Ruiz-Pérez LM.
Pacanowska DG.
Gilbert IH.
J. Med. Chem.
1999,
42:
4300
<A NAME="RW15209ST-17B">17b </A>
Chowdhury SF.
Guerrero
RH.
Brun R.
Ruiz-Pérez LM.
Pacanowska DG.
Gilbert IH.
J. Enzym. Inhib. Med. Chem.
2002,
17:
293
<A NAME="RW15209ST-17C">17c </A>
Pez D.
Leal I.
Zuccotto F.
Boussard C.
Brun R.
Croft SL.
Yardley V.
Ruiz-Pérez LM.
Gonzalez-Pacanowska D.
Gilbert IH.
Bioorg.
Med. Chem.
2003,
11:
4693
<A NAME="RW15209ST-18">18 </A>
Vaidya CM.
Wright JE.
Rosowsky A.
J.
Med. Chem.
2002,
45:
1690
<A NAME="RW15209ST-19">19 </A>
Stevens MFG.
J. Chem. Soc. C
1967,
1096
<A NAME="RW15209ST-20">20 </A>
Sutherland DR.
Tennant G.
J. Chem. Soc., Perkin Trans. 1
1974,
534
<A NAME="RW15209ST-21">21 </A>
Seijas JA.
Vázquez-Tato MP.
Martínez MM.
Tetrahedron Lett.
2000,
41:
2215
<A NAME="RW15209ST-22">22 </A>
Rad-Moghadam K.
Samavi L.
J. Heterocycl. Chem.
2006,
43:
913
<A NAME="RW15209ST-23">23 </A>
Rosowsky A.
Chen H.
J. Org. Chem.
2001,
66:
7522
For recent reviews on copper-catalyzed N -arylation, see:
<A NAME="RW15209ST-24A">24a </A>
Kunz K.
Scholz U.
Ganzer D.
Synlett
2003,
2428
<A NAME="RW15209ST-24B">24b </A>
Ley SV.
Thomas AW.
Angew.
Chem. Int. Ed.
2003,
42:
5400
<A NAME="RW15209ST-24C">24c </A>
Beletskaya IP.
Cheprakov AV.
Coord. Chem.
Rev.
2004,
248:
2337
<A NAME="RW15209ST-24D">24d </A>
Evano G.
Blanchard N.
Toumi M.
Chem.
Rev.
2008,
108:
3054 ;
and references cited therein
For recent studies on the synthesis
of N-heterocycles through Ullmann-type couplings, see:
<A NAME="RW15209ST-25A">25a </A>
Martin R.
Rodríguez R.
Buchwald SL.
Angew. Chem. Int. Ed.
2006,
45:
7079
<A NAME="RW15209ST-25B">25b </A>
Evindar G.
Batey RA.
J. Org. Chem.
2006,
71:
1802
<A NAME="RW15209ST-25C">25c </A>
Bonnaterre F.
Bois-Choussy M.
Zhu J.
Org. Lett.
2006,
8:
4351
<A NAME="RW15209ST-25D">25d </A>
Zou B.
Yuan Q.
Ma D.
Angew. Chem.
Int. Ed.
2007,
46:
2598
<A NAME="RW15209ST-25E">25e </A>
Yuan X.
Xu X.
Zhou X.
Yuan J.
Mai L.
Li Y.
J.
Org. Chem.
2007,
72:
1510
<A NAME="RW15209ST-26A">26a </A>
Liu X.
Fu H.
Jiang Y.
Zhao Y.
Angew. Chem.
Int. Ed.
2009,
48:
348
<A NAME="RW15209ST-26B">26b </A>
Huang C.
Fu Y.
Fu H.
Jiang Y.
Zhao Y.
Chem. Commun.
2008,
6333
<A NAME="RW15209ST-26C">26c </A>
Yang D.
Fu H.
Hu L.
Jiang Y.
Zhao Y.
J. Org. Chem.
2008,
73:
7841
<A NAME="RW15209ST-27">27 </A>
General Procedure
for the Synthesis of Compounds 3a-m
A
25 mL round-bottom flask was charged with a magnetic stirrer
and DMF (3 mL), substituted 2-bromobenzonitrile (1 , 1
mmol), amidine hydrochloride (2 , 1.2 mmol),
DMEDA (0.2 mmol, 18 mg), and K2 CO3 (2 mmol,
138 mg) [2 mmol (656 mg) of Cs2 CO3 were
used for acetamidine hydro-chloride] after stirring of
the mixture for 15 min under nitrogen atmosphere, and CuI (0.1 mmol,
19 mg) was added to the flask. The mixture was stirred at 80 ˚C
for the time indicated in Table
[² ]
.
The resulting mixture was cooled to r.t. and filtered. The solid
was washed with DMF (2 × 3 mL), and the
combined filtrate was concentrated by the rotary evaporator, and
the residue was purified by column chromatography on silica gel
using CHCl3 -MeOH (40:1 to 5:1) as eluent to
give the desired product.
Cyclopropyl-4-aminoquinazoline
(3c)
Eluent CHCl3 -MeOH (40:1).
Yield 134 mg (72%). White solid; mp 198-200 ˚C. ¹ H
NMR (300 MHz, DMSO-d
6 ): δ = 8.12
(d, 1 H, J = 7.9
Hz), 7.58 (m, 4 H), 7.34 (t, 1 H, J = 7.4 Hz),
1.99 (m, 1 H, J = 7.5
Hz), 1.05-0.87 (m, 4 H). ¹³ C
NMR (75 MHz, DMSO-d
6 ): δ = 167.6,
162.3, 150.5, 133.2, 126.9, 124.5, 124.0, 113.4, 18.4, 9.4. HRMS: m/z calcd for C11 H11 N3 [M + H]+ :
186.1031; found: 186.1037.